243.47
price up icon1.03%   2.49
after-market Handel nachbörslich: 243.65 0.18 +0.07%
loading
Schlusskurs vom Vortag:
$240.98
Offen:
$241.98
24-Stunden-Volumen:
268.18K
Relative Volume:
0.70
Marktkapitalisierung:
$6.27B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-8.9085
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
+4.94%
1M Leistung:
+8.80%
6M Leistung:
-26.53%
1J Leistung:
-12.43%
1-Tages-Spanne:
Value
$239.70
$246.50
1-Wochen-Bereich:
Value
$228.40
$246.50
52-Wochen-Spanne:
Value
$211.43
$387.99

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name
Firmenname
Bio Rad Laboratories Inc
Name
Telefon
(510) 724-7000
Name
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Name
Mitarbeiter
7,700
Name
Twitter
@BioRadLifeSci
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
BIO's Discussions on Twitter

Vergleichen Sie BIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BIO
Bio Rad Laboratories Inc
243.47 6.27B 2.58B -778.69M 223.75M -27.33
Medical Devices icon
ABT
Abbott Laboratories
133.67 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.58 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
390.40 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
86.18 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.15 44.46B 5.54B 4.18B 623.10M 7.00

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-01 Hochstufung Citigroup Neutral → Buy
2024-08-28 Eingeleitet Wells Fargo Equal Weight
2024-06-03 Fortgesetzt Jefferies Hold
2024-04-03 Herabstufung Citigroup Buy → Neutral
2023-12-07 Eingeleitet UBS Buy
2023-06-16 Eingeleitet Wells Fargo Overweight
2022-12-07 Eingeleitet RBC Capital Mkts Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-01-28 Bestätigt Citigroup Buy
2020-01-08 Eingeleitet Wells Fargo Overweight
2020-01-07 Eingeleitet Citigroup Buy
2018-10-17 Eingeleitet Goldman Buy
2018-09-20 Eingeleitet Morgan Stanley Equal-Weight
2018-02-16 Herabstufung CL King Buy → Neutral
2017-07-13 Eingeleitet Wells Fargo Outperform
2017-06-28 Hochstufung Deutsche Bank Hold → Buy
2017-01-18 Eingeleitet Deutsche Bank Hold
2016-10-13 Eingeleitet CL King Buy
2015-05-06 Bestätigt Jefferies Buy
2009-12-18 Eingeleitet Maxim Group Buy
2009-11-06 Eingeleitet Jefferies & Co Buy
2009-07-17 Eingeleitet Soleil Buy
2007-09-26 Eingeleitet Banc of America Sec Buy
2007-02-23 Herabstufung Robert W. Baird Outperform → Neutral
Alle ansehen

Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten

pulisher
Jun 19, 2025

Transfection Reagents and Equipment Market | Driving Gene - openPR.com

Jun 19, 2025
pulisher
Jun 18, 2025

Global Gene Expression Analysis Market | RNA Sequencing & PCR - openPR.com

Jun 18, 2025
pulisher
Jun 17, 2025

Bio-Rad extends anti-idiotypic antibody and SpyCatcher Reagent ranges for bioanalysis and antibody drug development - Cambridge Network

Jun 17, 2025
pulisher
Jun 17, 2025

Global Gel Electrophoresis Equipment Market Surges Amid Rising - openPR.com

Jun 17, 2025
pulisher
Jun 16, 2025

DNA Extraction Kits Market Future Business Opportunities - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Protein Engineering Market Fueled by AI, Genomics, - openPR.com

Jun 16, 2025
pulisher
Jun 13, 2025

Immunohistochemistry Market Trends | Cancer Diagnosis & - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

How to Take Advantage of moves in (BIO) - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 12, 2025

Global Genomics Market Surges Toward USD 115.4 Billion - openPR.com

Jun 12, 2025
pulisher
Jun 12, 2025

Genetic Testing Market Surges Amid Rising Demand - openPR.com

Jun 12, 2025
pulisher
Jun 11, 2025

Immunohematology Market Booming with Increased Blood Screening Initiatives | Bio-Rad Laboratories, Immucor Inc. - openPR.com

Jun 11, 2025
pulisher
Jun 11, 2025

Protein Analyzers Market Projected to Rise with Increased Focus - openPR.com

Jun 11, 2025
pulisher
Jun 11, 2025

Biopharmaceutical Processing Equipment and Consumables - openPR.com

Jun 11, 2025
pulisher
Jun 11, 2025

One Step RT-qPCR Kits Market Top Companies StudyTakara Bio - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Analysts Offer Insights on Healthcare Companies: Bio-Rad Laboratories (BIO) and Ramsay Health Care (OtherRMSYF) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Horseradish Peroxidase Market Size, Share & Trends | Industry - openPR.com

Jun 10, 2025
pulisher
Jun 10, 2025

Cell Biology Market Set to Experience Research Technology - openPR.com

Jun 10, 2025
pulisher
Jun 09, 2025

5 Analysts Have This To Say About Bio-Rad Laboratories - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Wells Fargo Lowers Price Target for Bio-Rad Laboratories (BIO) | BIO Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Europe Chromatography Resins Market Size, Outlook 2031 by Key - openPR.com

Jun 09, 2025
pulisher
Jun 08, 2025

Wells Fargo Adjusts Price Target for Bio-Rad (BIO), Maintains Eq - GuruFocus

Jun 08, 2025
pulisher
Jun 06, 2025

Food Diagnostics Market | Rapid Pathogen & Contaminant - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.

Jun 06, 2025
pulisher
Jun 06, 2025

Cancer Monoclonal Antibodies Market in 2025-2032 Detailed - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Next Generation Sequencing Market to Witness Upsurge in Growth - openPR.com

Jun 06, 2025
pulisher
Jun 05, 2025

bio-rad laboratories stock highlighted in cantor fitzgerald report - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

bio-rad laboratories stock highlighted in cantor fitzgerald report By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Laboratory Proficiency Testing Market Set to Witness - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Minimal Residual Disease Testing Market Set to Witness - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Enzyme Linked Immunosorbent Assay Market reached US$ 2.14 - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Flow Cytometry Market Growth, Trends & Forecast 2025 | Global - openPR.com

Jun 05, 2025
pulisher
Jun 04, 2025

Immunohistochemistry Market Detailed in New Research Report - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1 - Insider Monkey

Jun 04, 2025
pulisher
Jun 04, 2025

Global Microarray Market Size, Share & Growth Forecast - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

How DNA Sequencing Is Revolutionizing Cancer Genomics and Rare - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Cell Viability Assays Market 2025 | Techniques, Applications & - openPR.com

Jun 03, 2025
pulisher
Jun 03, 2025

High Resolution Melting Analysis Market Detailed in New - openPR.com

Jun 03, 2025
pulisher
Jun 03, 2025

Gel Documentation Systems Market Projected to Witness Massive - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Cell Signaling Market in 2025-2032 Detailed Study Analysis with - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Neuroscience Antibodies and Assays Market Trends, Growth & - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com

May 31, 2025
pulisher
May 31, 2025

Bio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Wall Street Zen - Defense World

May 31, 2025

Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bio Rad Laboratories Inc-Aktie (BIO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
ENLOE COURTNEY C
EVP, General Counsel & Sec
Apr 24 '25
Option Exercise
0.00
186
0
196
PINKSTON ARNOLD A
Director
Apr 22 '25
Option Exercise
0.00
308
0
308
PEI MELINDA LITHERLAND
Director
Apr 22 '25
Option Exercise
0.00
308
0
308
HINCKLEY GREGORY K
Director
Apr 22 '25
Option Exercise
0.00
308
0
308
EDWARDS JEFFREY L
Director
Apr 22 '25
Option Exercise
0.00
308
0
308
Crowley Michael
EVP, GBL Commercial Operations
Mar 14 '25
Option Exercise
159.32
3,000
477,960
11,171
Crowley Michael
EVP, GBL Commercial Operations
Mar 14 '25
Sale
247.06
3,000
741,184
8,171
$309.83
price up icon 1.18%
medical_devices PHG
$24.08
price up icon 0.67%
medical_devices STE
$238.53
price down icon 0.77%
$85.04
price up icon 0.43%
$74.86
price up icon 2.90%
medical_devices EW
$77.15
price up icon 0.23%
Kapitalisierung:     |  Volumen (24h):